Every day, the MarketScreener team selects the most important news about public companies from around the world. For your reference, I will briefly summarize it.
Corporate performance:
- Abdon expects profits to decline as the company looks to cut costs to restore health.
- Munich Re plans to raise its dividend and buy back shares worth 1.5 billion euros.
- PubliciMatic soared 37% in after-hours trading after its quarterly results.
- PUMA reported a weak first half due to currency effects.
- Workday’s stock plunged 8% after its quarterly results.
- row The company on Tuesday forecast full-year sales below Wall Street expectations as consumer spending on major home improvements remains limited.
- Macy’s on Tuesday said it expects sales to fall below consensus this year due to weak demand for clothing and footwear and will close 150 stores by 2026 as part of a new turnaround plan.
In other news:
- Chevron has warned that Exxon Mobil and CNOOC’s right of first refusal on Hess’ major assets in Guyana could jeopardize its planned $53 billion takeover of Hess.
- The FTC has begun proceedings to block the Albertsons-Kroger merger.
- UniCredit is in talks to buy Polish banking group Vodeno from Warburg Pincus.
- KKR, Macquarie Group, EQT, Antin and Global Infrastructure Partners are among the potential buyers for Poland’s Cellnex shares, Bloomberg reports.
- Mr. Iberdrola completed the sale of $6.2 billion of assets to the Mexican state.
- Sunam has entered into exclusive negotiations to purchase Edison’s gas storage assets in Italy.
- Barry Callebaut will cut up to 2,500 jobs as part of cost-cutting measures.
- EQT has raised €22 billion for its latest private equity fund.
- Micron has begun mass production of memory chips for Nvidia’s artificial intelligence semiconductors.
- Roche is considering options for its lung disease drug Esbriet, whose sales are declining due to generic competition.
- CRH will take control of Australian company Adbri for A$3.2 per share.
- Samsonite is being courted and is weighing his options.
- Expedia plans to cut 1,500 jobs worldwide by 2024.
- Standard Chartered suspends new offshore investments by Chinese clients.
- Genmab and AbbVie have received FDA priority review for blood cancer treatment.
- Gilead receives FDA approval for expanded indication for HIV treatment.
- Schaeffler has announced a new factory in the United States.
- Sagard acquires Acceo from GIMV.
- Pharmanutra will merge its subsidiaries Junia Pharma and Alesco.
- In the face of U.S. reluctance, Schein may seek a London listing.
- Expedia – The online travel platform announced Monday night that it intends to cut approximately 1,500 jobs, or 9% of its workforce, worldwide as part of an “organizational and technological transformation.”
- Broadcom – The chipmaker has paused the sale of its Carbon Black security software business, Bloomberg reported Monday night, citing sources familiar with the matter.
- Metaplatform – Group CEO Mark Zuckerberg met with Prime Minister Fumio Kishida in Tokyo on Tuesday to discuss artificial intelligence as part of a tour of Asia.
- Intuitive Machines fell 20.1% in pre-market trading after the company said it had lost communications with the Odysseus spacecraft, which capsized after landing on the moon. The lunar expedition, originally scheduled to last seven to 10 days, will be shortened to five days.
- Bristol-Myers Squibb wants to expand its research and development (R&D) presence in India and expects its new site in Hyderabad to become its largest division outside the United States by 2025, a managing director said. Director Christopher Werner said Tuesday.
- Walt Disney – David Greenbaum has been appointed to the newly created position of president of Walt Disney Studios, overseeing Disney Live Action and 20th Century Studios. He will report directly to Alan Bergman, co-president of Disney Entertainment.
- Family Dollar Stores, a subsidiary of discount retailer Dollar Tree, admitted Monday that it stored food, medicine and cosmetics in unsanitary conditions in a rodent-infested warehouse in Arkansas, resulting in $41.67 million in damages. The U.S. Department of Justice announced that the company has agreed to pay $1,000.
